Trustedge Capital Publishes FY26 Audited Results; Reports Net Profit of ₹54.60 Lakhs

5 min read     Updated on 13 May 2026, 01:55 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Trustedge Capital Limited approved its audited standalone financial results for FY26, reporting net profit of ₹54.60 lakhs and total income of ₹537.09 lakhs, with total assets growing to ₹7,102.53 lakhs. The results were published in Business Standard and Jai Hind on May 13, 2026, per SEBI Regulation 47. The board also designated two Senior Management Personnel and accepted the resignation of Independent Director Mr. Ketan Sanghvi.

powered bylight_fuzz_icon
40138859

*this image is generated using AI for illustrative purposes only.

Trustedge Capital Limited (formerly known as Adinath Exim Resources Limited) held a Board of Directors meeting on May 12, 2026, approving audited standalone financial results for the quarter and financial year ended March 31, 2026, along with key personnel changes and governance updates. The board meeting commenced at 02:30 PM IST and concluded at 04:00 PM IST. In compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company subsequently published the audited standalone financial results in Business Standard (English) and Jai Hind (Gujarati) on May 13, 2026. The statutory audit was conducted by M/s Mahendra N. Shah & Co., Chartered Accountants (FRN: 105775W), who issued an unmodified opinion on the financial results. The full format of the results is available on the BSE website ( www.bseindia.com ) and the company's website ( www.trustedgecapital.in ).

Financial Performance: FY26 vs FY25

The company reported a marked improvement in its financial performance for the year ended March 31, 2026. Total income surged to ₹537.09 lakhs from ₹109.32 lakhs in the previous year, driven primarily by a significant increase in interest income and the addition of fee and commission income. Net profit after tax stood at ₹54.60 lakhs for FY26, compared to ₹16.49 lakhs in FY25. The following table summarises the key financial metrics (all figures in ₹ Lakhs unless otherwise stated):

Metric: Q4 FY26 (31.03.2026) Q3 FY26 (31.12.2025) Q4 FY25 (31.03.2025) FY26 (Year Ended 31.03.2026) FY25 (Year Ended 31.03.2025)
Interest Income: 200.88 115.99 25.80 455.84 104.17
Fee and Commission Income: 23.02 12.23 - 42.46 -
Total Revenue from Operations: 223.90 131.07 26.54 522.33 109.32
Other Income: 4.30 10.46 - 14.76 -
Total Income: 228.20 141.53 26.54 537.09 109.32
Total Expenses: 180.29 121.92 65.25 500.81 87.28
Profit/(Loss) Before Tax: 47.91 19.61 (38.71) 36.28 22.04
Net Profit/(Loss) After Tax: 64.26 13.78 (28.97) 54.60 16.49
Total Comprehensive Income/(Expense): 30.56 18.45 (56.69) 46.66 51.73
Basic EPS (₹, not annualised): 0.67 0.15 (0.55) 0.72 0.31
Diluted EPS (₹, not annualised): 0.65 0.15 (0.55) 0.69 0.31

Balance Sheet Highlights as at March 31, 2026

The company's total assets grew substantially to ₹7,102.53 lakhs as at March 31, 2026, compared to ₹2,311.81 lakhs as at March 31, 2025. The loan book expanded significantly to ₹6,094.31 lakhs from ₹1,101.50 lakhs in the prior year, reflecting the company's active lending operations as a Non-Banking Financial Company (NBFC). Equity also strengthened, with total equity rising to ₹5,525.42 lakhs from ₹2,258.58 lakhs, supported by a paid-up equity share capital of ₹922.80 lakhs and other equity of ₹4,602.62 lakhs.

Balance Sheet Item: As at 31.03.2026 (₹ Lakhs) As at 31.03.2025 (₹ Lakhs)
Cash and Cash Equivalents: 181.22 485.14
Loans: 6,094.31 1,101.50
Investments: 636.94 707.48
Total Financial Assets: 7,041.63 2,303.42
Total Assets: 7,102.53 2,311.81
Borrowings (other than Debt Securities): 1,000.00 -
Total Financial Liabilities: 1,481.78 23.16
Equity Share Capital: 922.80 496.86
Other Equity: 4,602.62 1,761.72
Total Equity: 5,525.42 2,258.58

Rights Issue Utilisation

During the previous quarter, the company allotted 33,74,428 fully paid-up equity shares on a rights basis at an issue price of ₹80 per share (including share premium of ₹70 per share), aggregating to ₹2,699.54 lakhs, in the ratio of 49 rights equity shares for every 85 fully paid-up equity shares held by eligible shareholders as on the record date of October 1, 2025. The net proceeds were proposed to be utilised as follows:

  • Augmentation of capital base for onward lending: ₹1,988 lakhs
  • General corporate purposes: ₹673.15 lakhs
  • Issue related expenses: ₹38.39 lakhs

During the previous quarter, the company utilised ₹1,925 lakhs towards augmentation of capital base, ₹568.77 lakhs towards general corporate purposes, and ₹38.39 lakhs towards issue-related expenses. During the current quarter under review, the company utilised the remaining ₹63 lakhs towards augmentation of capital base and ₹104.38 lakhs towards general corporate purposes.

Internal Auditor Re-Appointment

Based on the recommendation of the Audit Committee, the Board re-appointed M/s MGP & Associates, Chartered Accountants (FRN: 140164W), as Internal Auditors of the company for the financial year ending March 31, 2027, with effect from May 12, 2026. MGP & Associates is a Chartered Accountancy firm founded in 2014, offering services including audit, tax advisory, management consultancy, financial management, accounting, secretarial, and corporate advisory services across a broad spectrum of industries. The firm is not related to any of the directors of the company.

Senior Management Personnel Designations

Pursuant to the recommendations of the Nomination and Remuneration Committee, the Board designated two individuals as Senior Management Personnel with effect from May 12, 2026:

Parameter: Mr. Somit Bhandari Mr. Chetan Khosla
Designation: Business Head – Credit & Strategy Business Head
Effective Date: May 12, 2026 May 12, 2026
Qualification: Chartered Accountant MBA
Experience: 25+ years across financial institutions 20+ years in the Indian financial sector
Key Expertise: Relationship, Credit, Product Management; Supply Chain Finance; Trade Finance SME and Emerging Corporate segments; portfolio management; risk and governance
Notable Prior Roles: Business Head (South SME) at IndusInd Bank; DBS, Barclays, ICICI Bank Circle Head at Axis Bank (Mumbai); ICICI Bank; Yes Bank

Resignation of Independent Director

Mr. Ketan Harsukhlal Sanghvi (DIN: 06531676) tendered his resignation from the position of Non-Executive Independent Director of the company with effect from the closing of business hours on May 12, 2026, citing health reasons. Consequent to his resignation, he also ceased to be the Chairman of the Audit Committee, Nomination and Remuneration Committee, and Stakeholder Relationship Committee of the company. Mr. Ketan Sanghvi confirmed in his resignation letter dated May 12, 2026, that there are no other material reasons for his resignation beyond those stated. He held no directorships or committee memberships in any other listed companies at the time of his resignation.

Historical Stock Returns for Trustedge Capital

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-5.60%-13.80%+74.30%+183.20%+2,268.09%

How will Trustedge Capital plan to manage asset quality risks as its loan book expands nearly 5.5x to ₹6,094 lakhs, and what NPA provisioning strategies are being considered for FY27?

With Mr. Somit Bhandari and Mr. Chetan Khosla joining as Business Heads focused on credit, SME, and supply chain finance, what new lending verticals or geographies is Trustedge Capital likely to target for growth in FY27?

Following Mr. Ketan Sanghvi's resignation as Independent Director and Chairman of three key committees, how quickly will the company reconstitute its Audit, NRC, and Stakeholder Relationship Committees to maintain regulatory compliance under SEBI LODR?

Trustedge Capital Cancels and Regrants 24,967 Employee Stock Options Under TEDGE ESOS 2025

2 min read     Updated on 12 May 2026, 08:14 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Trustedge Capital Limited's Nomination and Remuneration Committee, at its meeting on May 12, 2026, cancelled 24,967 unvested stock options under TEDGE ESOS 2025 following an employee's resignation, and subsequently approved a fresh grant of 24,967 stock options to eligible employees on the same date. Each option is convertible into one equity share at a face value of ₹ 10/- each, granted at face value in compliance with SEBI (SBE) Regulations, 2021. Vested options are exercisable within 5 years from the date of vesting, and the cancelled options have been returned to the option pool for future grants.

powered bylight_fuzz_icon
40142653

*this image is generated using AI for illustrative purposes only.

The Nomination and Remuneration Committee of Trustedge Capital Limited (formerly known as Adinath Exim Resources Limited) convened a meeting on May 12, 2026, and passed resolutions approving two key actions under the Trustedge Employee Stock Option Scheme 2025 (TEDGE ESOS 2025): the cancellation of unvested stock options and a fresh grant of stock options to eligible employees. The company made this disclosure to BSE Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Cancellation of Unvested Stock Options

The committee took note of the cancellation of 24,967 unvested stock options that had been previously granted to an employee under the TEDGE ESOS 2025. The cancellation was triggered by the resignation of the employee to whom the options were originally granted. As per the terms of the scheme, the cancelled options have been added back to the option pool and will be available for future grants in accordance with applicable laws.

Parameter: Details
Scheme Name: Trustedge Employee Stock Option Scheme 2025 (TEDGE ESOS 2025)
Total Options Cancelled: 24,967
Reason for Cancellation: Resignation of the employee to whom options were granted
Status of Cancelled Options: Added back to the option pool for future grants

Fresh Grant of Stock Options

Following the cancellation, the Nomination and Remuneration Committee approved the grant of 24,967 stock options to eligible employees under the TEDGE ESOS 2025, with an effective grant date of May 12, 2026. Each option is convertible into one equity share of the company at a face value of ₹ 10/- each. The options have been granted at face value, i.e., ₹ 10, pursuant to the applicable provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Parameter: Details
Options Granted: 24,967
Effective Grant Date: May 12, 2026
Face Value per Share: ₹ 10/-
Total Shares Covered: 24,967 equity shares of face value ₹ 10/- each
Pricing Formula: Face value, i.e., ₹ 10
Exercise Period: Within 5 years from the date of vesting, or such other period as determined by the Committee
Scheme Compliance: SEBI (SBE) Regulations, 2021

Key Terms of TEDGE ESOS 2025

The TEDGE ESOS 2025 is administered by the Nomination and Remuneration Committee. The scheme outlines the following significant terms:

  • Objective: To align the interests of employees with the long-term goals of the company by offering them an opportunity to become shareholders.
  • Purpose: Designed to compensate and recognize performance, attract and retain talent, and drive future growth.
  • Grant Basis: Options shall be granted based on one or more pre-defined performance conditions as determined by the Committee.
  • Exercise Window: Vested options may be exercised anytime within the exercise window(s) as intimated by the company, provided it is within a period of 5 years from the date of vesting or such other period as determined by the Committee. All vested options can be exercised by the option grantee at one time within the exercise period.

The disclosure, along with Annexure-A containing details as required under SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, has been uploaded on the company's website. The intimation was signed by Manoj S. Savla, Chairman & Managing Director of Trustedge Capital Limited.

Historical Stock Returns for Trustedge Capital

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-5.60%-13.80%+74.30%+183.20%+2,268.09%

How might Trustedge Capital's decision to grant options at face value (₹10) rather than market price impact employee retention and the company's ability to attract senior talent compared to industry peers?

Given that the entire cancelled option pool was immediately re-granted to new eligible employees, what does this suggest about the company's talent acquisition strategy and pipeline under its rebranding from Adinath Exim Resources?

How could the 5-year exercise window post-vesting under TEDGE ESOS 2025 influence the potential dilution of existing shareholders' equity as the company scales its operations?

More News on Trustedge Capital

1 Year Returns:+183.20%